Clinical Trial Update: Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating acarbose and a mixture of pioglitazone and metformin for Type 2 Diabetes and blood glucose fluctuation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Acarbose (acarbose)
• Pioglitazone/metformin (pioglitazone/metformin)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Type 2 Diabetes, Blood Glucose Fluctuation | Phase 3 | Status: UNKNOWN